Firazyr
NDC 54092-702, icatibant acetate, injection, solution, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 54092-702
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022150
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54092-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICATIBANT ACETATE30 mg/3mL
Pharmacologic classes
Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54092-702-01 | 54092070201 | 1 SYRINGE, GLASS in 1 CARTON (54092-702-01) / 3 mL in 1 SYRINGE, GLASS |
| 54092-702-02 | 54092070202 | 1 SYRINGE, GLASS in 1 CARTON (54092-702-02) / 3 mL in 1 SYRINGE, GLASS |
| 54092-702-03 | 54092070203 | 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ed6657ca-ab68-477a-9968-e12dc928b540
Use it
Look up 54092-702 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54092-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54092-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.